Patents by Inventor Lawrence M. Kauvar

Lawrence M. Kauvar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100151481
    Abstract: Assays for detecting the presence and activity of cell-signaling components. These assays include luminescence polarization assays for detecting cell-signaling nucleotides and modulators of receptors and enzymes related to the generation and activity of such nucleotides.
    Type: Application
    Filed: February 25, 2010
    Publication date: June 17, 2010
    Inventors: J. Richard Sportsman, Lawrence M. Kauvar
  • Patent number: 7736648
    Abstract: Individual monoclonal antibodies and fragments that bind a conserved epitope of the G protein of RSV and which are minimally immunogenic when administered to a human subject, are useful in treating RSV infections.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: June 15, 2010
    Assignee: Trellis Bioscience, Inc.
    Inventors: Lawrence M. Kauvar, Ellen J. Collarini, Bruce Keyt, Orit Foord
  • Publication number: 20090221434
    Abstract: New applications for the use of distinguishable particulate labels available in a variety of hues and sized in the submicron range are described. These applications include profiling of cellular components, obtaining secretion patterns, identifying a multiplicity of components in chromatographic or electrophoretic techniques and identification of desired immunoglobulin secreting cells.
    Type: Application
    Filed: August 8, 2008
    Publication date: September 3, 2009
    Inventors: Lawrence M. Kauvar, Remy Cromer, William D. Harriman, Ellen J. Collarini
  • Publication number: 20090130120
    Abstract: Individual monoclonal antibodies and fragments that bind a conserved epitope of the G protein of RSV and which are minimally immunogenic when administered to a human subject, are useful in treating RSV infections.
    Type: Application
    Filed: October 24, 2008
    Publication date: May 21, 2009
    Inventors: Lawrence M. KAUVAR, Ellen J. Collarini, Bruce Keyt, Orit Foord
  • Patent number: 7504230
    Abstract: The present invention is a cell-based method of identifying a set of signal transduction proteins having an intracellular localization pattern responsive to toxic compounds. The method requires identifying and screening an initial set of signal transduction proteins against a set of toxic compounds, and determining changes in intracellular localization pattern of each of the proteins. Proteins whose changes in intracellular localization pattern are redundant are discarded from the initial set, and new proteins are added to provide a new set of proteins. I repeat the method steps with new sets of proteins until the set of proteins provides me at least 5 principal components with respect to the range of compounds marketed as small organic molecules.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: March 17, 2009
    Assignee: Trelolis Bioscience, Inc.
    Inventor: Lawrence M. Kauvar
  • Patent number: 7413868
    Abstract: New applications for the use of distinguishable particulate labels available in a variety of hues and sized in the submicron range are described. These applications include profiling of cellular components, obtaining secretion patterns, identifying a multiplicity of components in chromatographic or electrophoretic techniques and identification of desired immunoglobulin secreting cells.
    Type: Grant
    Filed: November 3, 2004
    Date of Patent: August 19, 2008
    Assignee: Trellis Bioscience, Inc.
    Inventors: Lawrence M. Kauvar, Remy Cromer, William D. Harriman, Ellen J. Collarini
  • Patent number: 7238490
    Abstract: Intermolecular binding can be detected by formation of a “paratope” which results in an immediate generation of a signal. The substances to be tested for interaction are bound to demitopes, wherein said demitopes are components of a paratope which binds a reporter which provides said signal when bound. Known interactions measured in this way can also be employed to screen for compounds which interfere with the interactions. In addition to testing for individual interactions, the interaction of a compound with a library or library×library interactions can also be determined and the effect of potentially interfering substances evaluated.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: July 3, 2007
    Assignee: Trellis Bioscience, Inc.
    Inventor: Lawrence M. Kauvar
  • Patent number: 7060447
    Abstract: Intracellular translocation of proteins, particularly protein kinase C (PKC) isoenzymes, provides a surrogate test system for determining toxicity of candidate compounds. The profile of translocation with respect to at least one and preferably two or more signal transduction proteins can be correlated with-that of known toxins. In addition, databases of such profiles with respect to toxins of various types provide a useful set of standards for evaluating toxicity of candidate compounds. Moreover, to the extent that a toxin's profile mimics that found in a diseased state, the toxin can be used to construct screens for compounds alleviating the disease.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: June 13, 2006
    Assignee: Trellis Bioscience, Inc.
    Inventor: Lawrence M. Kauvar
  • Patent number: 7029695
    Abstract: Pharmaceutical compositions and methods of using them. Lipid formulations of a glutathione analog and methods of manufacturing them. Their use to stimulate hematopoiesis, protect hematopoietic cells from damage caused by radiation or chemotherapy, or potentiate the stimulatory action of one or a combination of cytokines on colony formation by hematopoietic progenitor cells, protect a subject from a destructive effect of a chemotherapeutic agent or irradiation, or to potentiate the effect of a chemotherapeutic agent.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: April 18, 2006
    Assignee: Telik, Inc.
    Inventors: Thomas Redelmeier, Lawrence M. Kauvar, Robert T. Lum, Matthew H. Lyttle, Robert W. Macsata, Steven R. Schow, Hugo O. Villar, Michael R. Kozlowski
  • Patent number: 6936427
    Abstract: Intermolecular binding can be detected by formation of a “paratope” which results in an immediate generation of a signal. The substances to be tested for interaction are bound to demitopes, wherein said demitopes are components of a paratope which binds a reporter which provides said signal when bound. Known interactions measured in this way can also be employed to screen for compounds which interfere with the interactions. In addition to testing for individual interactions, the interaction of a compound with a library or library×library interactions can also be determined and the effect of potentially interfering substances evaluated.
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: August 30, 2005
    Assignee: Trellis Bioscience, Inc.
    Inventor: Lawrence M. Kauvar
  • Patent number: 6867007
    Abstract: Effector functions are provided to a desired target with improved specificity by use of two or more complementary targeting components. The targeting components assemble a functional moiety at the target. At the target, the functional moiety itself provides an effector function or binds to additional components which provide an effector function. The effector function may be an enzymatic activity, a label or a signal. The binary or polynary targeting system may be used for analyte determination as well.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: March 15, 2005
    Assignee: Trellis Bioscience, Inc.
    Inventor: Lawrence M. Kauvar
  • Patent number: 6806053
    Abstract: Assays for detecting the presence and activity of cell-signaling components. These assays include luminescence polarization assays for detecting cell-signaling nucleotides and modulators of receptors and enzymes related to the generation and activity of such nucleotides.
    Type: Grant
    Filed: January 23, 2001
    Date of Patent: October 19, 2004
    Assignee: LJL BioSystems, Inc.
    Inventors: J. Richard Sportsman, Lawrence M. Kauvar
  • Publication number: 20040203000
    Abstract: Assays for detecting the presence and activity of cell-signaling components. These assays include luminescence polarization assays for detecting cell-signaling nucleotides and modulators of receptors and enzymes related to the generation and activity of such nucleotides.
    Type: Application
    Filed: January 23, 2001
    Publication date: October 14, 2004
    Applicant: LJL BioSystems, Inc.
    Inventors: J. Richard Sportsman, Lawrence M. Kauvar
  • Publication number: 20040185467
    Abstract: Improved methods using microscope based detection for identifying nucleic acid polymorphisms rely on localizing the region to be tested using particulate labels. The length of a segment containing tandem repeats can be determined by the intensity of signal emitted by a fluorophore associated with the repeat and bracketed by the labels; the presence of an allele containing a restriction site can be identified by viewing the association or dissociation of particulate labels. Single nucleotide polymorphisms characterized by the presence or absence of a referent base can be detected with a large differential in binding energy using short probes, by virtue of localizing the base to be interrogated with flanking particulate labels. The methods may be performed on a multiplicity of test nucleic acids simultaneously by employing a multiplicity of particulate labels with differing hues.
    Type: Application
    Filed: November 13, 2003
    Publication date: September 23, 2004
    Inventors: Lawrence M. Kauvar, Magnus Strandh, Remy Cromer
  • Publication number: 20040161797
    Abstract: Intracellular translocation of proteins, particularly protein kinase C (PKC) isoenzymes, provides a surrogate test system for determining toxicity of candidate compounds. The profile of translocation with respect to at least one and preferably two or more signal transduction proteins can be correlated with that of known toxins. In addition, databases of such profiles with respect to toxins of various types provide a useful set of standards for evaluating toxicity of candidate compounds. Moreover, to the extent that a toxin's profile mimics that found in a diseased state, the toxin can be used to construct screens for compounds alleviating the disease.
    Type: Application
    Filed: November 13, 2003
    Publication date: August 19, 2004
    Inventor: Lawrence M. Kauvar
  • Publication number: 20040126901
    Abstract: Compositions and methods which permit effective use of multiplexed particles of dimensions less than the resolution of the detector are useful in assessing the spatial pattern of targets or substructures within a specific environment.
    Type: Application
    Filed: October 7, 2003
    Publication date: July 1, 2004
    Inventors: Lawrence M. Kauvar, William D. Harriman
  • Publication number: 20040110237
    Abstract: Intracellular translocation of proteins, particularly protein kinase C (PKC) isoenzymes, provides a surrogate test system for determining toxicity of candidate compounds. The profile of translocation with respect to at least one and preferably two or more signal transduction proteins can be correlated with-that of known toxins. In addition, databases of such profiles with respect to toxins of various types provide a useful set of standards for evaluating toxicity of candidate compounds. Moreover, to the extent that a toxin's profile mimics that found in a diseased state, the toxin can be used to construct screens for compounds alleviating the disease.
    Type: Application
    Filed: November 13, 2003
    Publication date: June 10, 2004
    Inventor: Lawrence M. Kauvar
  • Publication number: 20040072233
    Abstract: Particulate labels that can be individually identified comprise particulate supports to which are bound at least two distinguishable signal generating moieties, such as fluorophores emitting at different wavelengths, which signals are detectable and measurable in situ. By varying the ratio and/or amounts of the signal generating moieties, a multiplicity of different and distinguishable labels is obtained. Each different label can then be coupled to a different reagent and the individual interactions of each reagent with a target observed in parallel.
    Type: Application
    Filed: October 2, 2003
    Publication date: April 15, 2004
    Inventors: Lawrence M. Kauvar, John Sedat
  • Patent number: RE38915
    Abstract: Modulation of the activity of the insulin receptor, enhancement of glucose uptake by cells, and other effects significant in the control and management of diabetes are accomplished using compounds of the formula wherein each A is independently a proton-accepting substituent; each R is independently a noninterfering substituent; n is 0, 1, or 2; and each linker is independently an isostere of —NHCONH— or of —N?N— or of —NHCO—. Compounds in the genus of Formula (1) can also be used for structure activity studies to identify features responsible for the relevant activities.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: December 6, 2005
    Assignee: Telik, Inc.
    Inventors: Richard Sportsman, Hugo O. Villar, Lawrence M. Kauvar, Wayne R. Spevak
  • Patent number: RE39866
    Abstract: Modulation of the activity of the insulin receptor, enhancement of glucose uptake by cells, and other effects significant in the control and management of diabetes are accomplished using compounds of the formula wherein each A is independently a proton-accepting substituent; each R is independently a noninterfering substituent; n is 0, 1, or 2; and each linker is independently an isostere of —NHCONH— or of —N?N— or of —NHCO—. Compounds in the genus of Formula (1) can also be used for structure activity studies to identify features responsible for the relevant activities.
    Type: Grant
    Filed: June 23, 2005
    Date of Patent: October 2, 2007
    Assignee: Telik, Inc.
    Inventors: Richard Sportsman, Hugo O. Villar, Lawrence M Kauvar, Wayne R Spevak